Mitchell D. Creinin, MD

2020 Update on contraception

Although continuation rates and user satisfaction with LARC methods are high, a common reason for discontinuation is unfavorable...

The Essure permanent hysteroscopic contraceptive device will disappear from the market in 2019. We present a timeline of events leading to product...

Adopting the “opportunistic salpingectomy philosophy” for benign hysterectomies has been fairly easy for ObGyns, but what about for permanent...

The unique cost set-up of Liletta relies on physician uptake, which in turn relies on ease of useA new single-handed inserter (SHI) for placement...

A declining US unintended pregnancy rate is good news. Full access to IUDs could address the rate even more, for all patients.

It is slightly more effective, but both devices have a very low contraceptive failure rate, according to this multinational, prospective,...